|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Inventory net realizable value adjustment | |||||
| Bad debt (recovered) expensed | |||||
| Allowance for credit losses | |||||
| Loss on retirement of property and equipment | |||||
| Common stock issued to consultants for services | |||||
| Loss on extinguishment of short-term debt | |||||
| Accrued interest | |||||
| Amortization of short-term loan fees | |||||
| Change in fair value of warrant liability | |||||
| Offering costs allocated to warrant liability | |||||
| Offering costs allocated to warrants | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Operating lease right-of-use ("ROU") assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Accrued severance expense | |||||
| Operating lease liabilities | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net borrowings from short-term loan | |||||
| Repayments of short-term loan | |||||
| Repayments of financed insurance premiums | |||||
| Net proceeds from exercise of warrant liability | |||||
| Repayments of financed insurance | |||||
| Net proceeds from an ATM offering | |||||
| Net proceeds from a registered offering of common stock and warrants | |||||
| Net proceeds from a sale of common stock and warrant issuance | |||||
| Proceeds from contributions to the ESPP | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash - beginning | |||||
| Cash, cash equivalents and restricted cash - ending | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest paid | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Decrease in operating lease right-of-use assets and operating lease liabilities from incremental borrowing rate change | |||||
| Decrease in ROU assets and operating lease liabilities from lease amendment | |||||
| Increase in ROU assets and operating lease liabilities from lease modification | |||||
| Common stock issued | |||||
| Restricted Stock Units (RSUs) | |||||
| Common stock issued for RSUs | |||||
| Decrease in ROU assets from shares issued to landlord | |||||
| Accrued interest in short-term loan payable | |||||
| Reclassification of warrant liability to equity upon warrant exercise | |||||
| Financing of insurance premiums | |||||
Loading...